Literature DB >> 31165228

68Ga-PSMA-11 PET/CT in a patient with non-PSA-secreting undifferentiated prostate cancer before and after treatment with cabozantinib.

Carlos Artigas1, N Plouznikoff2,3, T Gil4, I Duran Derijckere2, M Herchuelz2, I Libert5, P Flamen2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31165228     DOI: 10.1007/s00259-019-04367-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  1 in total

1.  Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain.

Authors:  Felipe Couñago; Claudio Martínez-Ballesteros; Carlos Artigas; Ana Aurora Díaz-Gavela; Luis Leonardo Guerrero Gómez; María Eugenia Lillo-García; José Reinaldo Chicharo; Manuel Recio; Antonio Maldonado; Israel J Thuissard; Cristina Andreu-Vázquez; David Sanz-Rosa; Antonio José Conde-Moreno; Francisco José Marcos; Sofía Sánchez García; Juan Ignacio Martínez-Salamanca; Joaquin Carballido-Rodríguez; Javier Hornedo; Elia Del Cerro
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.